Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

729
Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
729
Alterations in Blood Pressure01:30

Alterations in Blood Pressure

2.5K
Alterations in blood pressure, such as hypertension (high blood pressure) and hypotension (low blood pressure), significantly affect human health. Understanding these conditions' classifications, causes, and symptoms is essential for effective management and treatment.
Hypertension (High blood pressure)
Hypertension occurs when blood pressure readings consistently exceed the normal range. It is diagnosed when systolic blood pressure (the top number, indicating pressure while the heart...
2.5K
Hypertension I: Introduction01:28

Hypertension I: Introduction

1.2K
Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...
1.2K
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

4.8K
Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
4.8K
Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

1.1K
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
1.1K
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

1.5K
Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
1.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Prevalence and Risk Factors for Secondary Hypertension in Young Adults.

Hypertension (Dallas, Tex. : 1979)ยท2024
Same author

Management of arterial hypertension: home blood pressure measurement is a cornerstone for telemonitoring and self-management.

mHealthยท2023
Same author

[Out-of-center blood pressure measurements in dialysis patients: Feasibility and comparison of methods].

Nephrologie & therapeutiqueยท2022
Same author

Revue medicale suisseยท2021
Same author

Renal Outcome and New-Onset Renal and Extrarenal Dissections in Patients With Nontrauma Renal Artery Dissection Associated With Renal Infarction.

Hypertension (Dallas, Tex. : 1979)ยท2021
Same author

Organ Transplantation in Hereditary Fibrinogen A ฮฑ-Chain Amyloidosis: A Case Series of French Patients.

American journal of kidney diseases : the official journal of the National Kidney Foundationยท2020

Related Experiment Video

Updated: Apr 5, 2026

A Laser-induced Mouse Model of Chronic Ocular Hypertension to Characterize Visual Defects
07:00

A Laser-induced Mouse Model of Chronic Ocular Hypertension to Characterize Visual Defects

Published on: August 14, 2013

13.7K

[Masked hypertension].

Guillaume Bobrie

    Bulletin De L'Academie Nationale De Medecine
    |August 12, 2015
    PubMed
    Summary
    This summary is machine-generated.

    Masked hypertension, high blood pressure detected outside clinic visits, is common in treated patients. It carries a poor cardiovascular prognosis, similar to sustained hypertension, despite normal in-office readings.

    More Related Videos

    A Magnetic Microbead Occlusion Model to Induce Ocular Hypertension-Dependent Glaucoma in Mice
    09:26

    A Magnetic Microbead Occlusion Model to Induce Ocular Hypertension-Dependent Glaucoma in Mice

    Published on: March 23, 2016

    20.9K
    A Reversible Silicon Oil-Induced Ocular Hypertension Model in Mice
    09:03

    A Reversible Silicon Oil-Induced Ocular Hypertension Model in Mice

    Published on: November 15, 2019

    11.1K

    Related Experiment Videos

    Last Updated: Apr 5, 2026

    A Laser-induced Mouse Model of Chronic Ocular Hypertension to Characterize Visual Defects
    07:00

    A Laser-induced Mouse Model of Chronic Ocular Hypertension to Characterize Visual Defects

    Published on: August 14, 2013

    13.7K
    A Magnetic Microbead Occlusion Model to Induce Ocular Hypertension-Dependent Glaucoma in Mice
    09:26

    A Magnetic Microbead Occlusion Model to Induce Ocular Hypertension-Dependent Glaucoma in Mice

    Published on: March 23, 2016

    20.9K
    A Reversible Silicon Oil-Induced Ocular Hypertension Model in Mice
    09:03

    A Reversible Silicon Oil-Induced Ocular Hypertension Model in Mice

    Published on: November 15, 2019

    11.1K

    Area of Science:

    • Cardiology
    • Hypertension Research
    • Clinical Medicine

    Context:

    • Masked hypertension is defined as normal blood pressure (BP) in a clinical setting but elevated BP during ambulatory or home monitoring.
    • This condition is prevalent, especially among individuals undergoing antihypertensive therapy.
    • It frequently coexists with other cardiovascular risk factors.

    Purpose:

    • To highlight the clinical significance and prognostic implications of masked hypertension.
    • To underscore the diagnostic challenge and potential underestimation of cardiovascular risk associated with this condition.

    Summary:

    • Masked hypertension presents a diagnostic dilemma, with normal readings in medical settings masking underlying high blood pressure.
    • Patients with masked hypertension exhibit a poorer cardiovascular prognosis, comparable to those with sustained hypertension.
    • The underlying pathophysiology remains unclear, and evidence from controlled treatment trials is lacking.

    Impact:

    • Recognizing masked hypertension is crucial for accurate cardiovascular risk assessment.
    • This condition may necessitate tailored management strategies beyond standard in-office BP monitoring.
    • Further research into its mechanisms and effective treatments is warranted to improve patient outcomes.